Toshihide Matsumoto

1.3k total citations
58 papers, 973 citations indexed

About

Toshihide Matsumoto is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Toshihide Matsumoto has authored 58 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Oncology and 8 papers in Surgery. Recurrent topics in Toshihide Matsumoto's work include Cancer Cells and Metastasis (9 papers), S100 Proteins and Annexins (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). Toshihide Matsumoto is often cited by papers focused on Cancer Cells and Metastasis (9 papers), S100 Proteins and Annexins (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). Toshihide Matsumoto collaborates with scholars based in Japan, Australia and United Kingdom. Toshihide Matsumoto's co-authors include Makoto Saegusa, Yuichi Sato, Ryo Nagashio, Miki Hashimura, Ako Yokoi, Taihei Kageyama, Yasuko Oguri, Yukitoshi Satoh, Isao Okayasu and Shinichiro Ryuge and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Toshihide Matsumoto

54 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshihide Matsumoto Japan 19 476 272 168 145 142 58 973
Andreas Doll Spain 20 714 1.5× 296 1.1× 344 2.0× 90 0.6× 314 2.2× 37 1.3k
Aytekin Akyol Türkiye 14 464 1.0× 313 1.2× 151 0.9× 91 0.6× 95 0.7× 40 964
Queeny K.Y. Chan Hong Kong 12 602 1.3× 233 0.9× 179 1.1× 66 0.5× 99 0.7× 12 960
Behrouz Zand United States 12 364 0.8× 350 1.3× 143 0.9× 204 1.4× 86 0.6× 34 869
Mingjun Zheng China 17 573 1.2× 196 0.7× 386 2.3× 121 0.8× 225 1.6× 46 907
Marina Rigau Spain 16 512 1.1× 168 0.6× 336 2.0× 82 0.6× 196 1.4× 23 925
Masafumi Toyoshima Japan 18 494 1.0× 231 0.8× 145 0.9× 90 0.6× 152 1.1× 61 1.1k
Heather S. Bevan United Kingdom 12 796 1.7× 226 0.8× 227 1.4× 78 0.5× 96 0.7× 12 1.1k
Justin Bottsford-Miller United States 16 559 1.2× 591 2.2× 324 1.9× 258 1.8× 163 1.1× 42 1.4k
Lilian Varricchio United States 19 493 1.0× 211 0.8× 76 0.5× 76 0.5× 184 1.3× 37 1.1k

Countries citing papers authored by Toshihide Matsumoto

Since Specialization
Citations

This map shows the geographic impact of Toshihide Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihide Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihide Matsumoto more than expected).

Fields of papers citing papers by Toshihide Matsumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihide Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihide Matsumoto. The network helps show where Toshihide Matsumoto may publish in the future.

Co-authorship network of co-authors of Toshihide Matsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihide Matsumoto. A scholar is included among the top collaborators of Toshihide Matsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihide Matsumoto. Toshihide Matsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Toshihide, Takayuki Uematsu, Fumitaka Kawakami, et al.. (2024). SARS-CoV-2 infection causes a decline in renal megalin expression and affects vitamin D metabolism in the kidney of K18-hACE2 mice. Scientific Reports. 14(1). 24313–24313.
4.
Yokoi, Ako, Miki Hashimura, Toshihide Matsumoto, et al.. (2022). A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma. Cell Communication and Signaling. 20(1). 46–46. 8 indexed citations
5.
Takahashi, Hiroyuki, Miki Hashimura, Toshihide Matsumoto, et al.. (2022). A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma. The Journal of Pathology Clinical Research. 8(5). 458–469. 13 indexed citations
6.
Matsumoto, Toshihide, Yoshinori Hasegawa, Miki Hashimura, et al.. (2021). Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma. American Journal Of Pathology. 191(10). 1837–1850. 12 indexed citations
7.
Matsumoto, Toshihide, et al.. (2020). Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma. Molecular Carcinogenesis. 59(12). 1409–1419. 6 indexed citations
8.
Oguri, Yasuko, Miki Hashimura, Ryo Konno, et al.. (2019). S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma. Laboratory Investigation. 100(5). 682–695. 28 indexed citations
10.
Takano, Shotaro, Kentaro Uchida, Gen Inoue, et al.. (2018). Vascular endothelial growth factor expression and their action in the synovial membranes of patients with painful knee osteoarthritis. BMC Musculoskeletal Disorders. 19(1). 204–204. 45 indexed citations
11.
Takano, Shingo, Kentaro Uchida, Gen Inoue, et al.. (2017). Nerve growth factor regulation and production by macrophages in osteoarthritic synovium. Clinical & Experimental Immunology. 190(2). 235–243. 60 indexed citations
12.
Wu, Fei, Miki Hashimura, Yasuko Oguri, et al.. (2017). A functional role of LEFTY during progesterone therapy for endometrial carcinoma. Cell Communication and Signaling. 15(1). 56–56. 13 indexed citations
13.
Uchida, Kentaro, Gen Inoue, Shotaro Takano, et al.. (2016). Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients. Journal of Orthopaedic Surgery and Research. 11(1). 117–117. 27 indexed citations
14.
Suzuki, Erina, Sabine Kajita, Hiroyuki Takahashi, et al.. (2015). Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Laboratory Investigation. 95(8). 962–972. 25 indexed citations
15.
Matsumoto, Kazumasa, Makoto Kobayashi, Toshihide Matsumoto, et al.. (2014). Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladder. Biomedical Research. 35(6). 351–356. 13 indexed citations
16.
Kobayashi, Makoto, Ryo Nagashio, Shinichiro Ryuge, et al.. (2014). Acquisition of useful sero-diagnostic autoantibodies using the same patients’sera and tumor tissues. Biomedical Research. 35(2). 133–143. 6 indexed citations
17.
Matsumoto, Kazumasa, Masaomi Ikeda, Toshihide Matsumoto, et al.. (2014). Serum Periplakin as a Potential Biomarker for Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention. 15(22). 9927–9931. 9 indexed citations
18.
Ryuge, Shinichiro, Yuichi Sato, Toshihide Matsumoto, et al.. (2010). Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer. CHEST Journal. 139(4). 862–869. 40 indexed citations
19.
Nagashio, Ryo, Yuichi Sato, Toshihide Matsumoto, et al.. (2009). Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas. Pathology International. 60(2). 71–77. 23 indexed citations
20.
Matsumoto, Toshihide, Ryo Nagashio, Taihei Kageyama, et al.. (2009). Proteomics of tumor‐specific proteins in cerebrospinal fluid of patients with astrocytoma: Usefulness of gelsolin protein. Pathology International. 59(11). 797–803. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026